Unsuspected reduced radiochemical purity of the 18F-FDG may decrease image resolution, SUV reliability and diagnostic accuracy.
Our aim was to identify the conditions required to stably maintain the radiochemical purity of fluorine-18-fluorodeoxyglucose (18F-FDG) above the Korean Pharmacology (KP) and United States Pharmacology (USP) standards for expiration time (time from the end of synthesis (EOS), 8h even at a high radioactive concentration exceeding 7.4GBq/mL. The changes in the radiochemical purity of 18F-FDG were assessed according to the changes in radioactive concentration, ethanol (EtOH) concentration, amount of water for dilution storage temperature, and storage volume. Controlling the radioactive concentration as much as possible during the production of 18F-FDG is necessary to improve the radiochemical purity of 18F-FDG. In the production of 18F-FDG, a radioactive concentration <7.4GBq/mL was sufficient to maintain the radiochemical purity above the KP and USP standards for 10h after the EOS. If the radioactive concentration exceeded 7.4GBq/mL during synthesis, the addition of EtOH to 18F-FDG is essential to maintain the radiochemical purity above the KP and USP standards. To minimize residual solvent EtOH production, the addition of 0.1% EtOH to the 18F-FDG is the ideal combination. Increasing the radiochemical purity of the 18F-FDG increases the quality of images, the reliabity of the SUV during PET scanning and consequently increases the accuracy of diagnosis. Furthermore, 18F-FDG can be synthesized at a high radioactive concentration in large volume, and its effective date could also be prolonged.